Peritoneal Cancer
Cancer
Peritoneal Cancer is treated with 1 medication in our database, including ELAHERE. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by "ImmunoGen, Inc.". Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Peritoneal Cancer treatment below.
What help exists for Peritoneal Cancer
10
drugs indexed
6
with copay cards
7
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Peritoneal Cancer
10 totalRubraca
rucaparib Β· Pharmaand
ππALYMSYS
bevacizumab-maly
ππLynparza
olaparib
ZEJULA
niraparib Β· GSK
ππELAHERE
MIRVETUXIMAB SORAVTANSINE
πJOBEVNE
bevacizumab-nwgd Β· Pharming Healthcare, Inc.
ππZirabev
bevacizumab-bvzr Β· Pfizer
ππMVASI
bevacizumab-awwb Β· Amgen
ππVegzelma
bevacizumab-adcd Β· Celltrion
Avastin
bevacizumab Β· Genentech
π = copay card Β· π = patient assistance program
Prior authorization patterns for Peritoneal Cancer drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |